上海医药：关于子公司成为氨磺必利口崩片上市许可持有人的公告

Core Viewpoint - Shanghai Pharmaceuticals announced the approval of a change in the marketing authorization holder for Amisulpride orally disintegrating tablets to its subsidiary, Shanghai Shiyou Zhongxi Pharmaceutical Co., Ltd. [1] Company Summary - Shanghai Pharmaceuticals' subsidiary, Shanghai Shiyou Zhongxi Pharmaceutical Co., Ltd., received the approval from the National Medical Products Administration for the change of marketing authorization holder [1]